Carparts.Com Inc vs Viatris Inc — how do they compare? Carparts.Com Inc trades at $8.59 (market cap $66.42M), while Viatris Inc trades at $17.49 (market cap $20.03B). The key difference: Viatris Inc is far larger — about 301.6× Carparts.Com Inc's market cap, and Viatris Inc pays a 2.75% dividend while Carparts.Com Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Carparts.Com Inc for 45 Days and Viatris Inc for 57 Days on average.
| PRTS | VTRS | |
|---|---|---|
Market Cap | $66.42M | $20.03B |
Volume | 40,287 | 14,109,977 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.00 | $18.27 |
52-Week Low | $3.88 | $9.74 |
Typical Hold Time | 45 Days | 57 Days |
Enterprise Value | $79.39M | $32.15B |
Dividend Yield | — | 2.75% |
Signals from Pluang's Aura AI — not financial advice
CarParts.com (PRTS) trades at $8.695, up 0.99% with a bullish technical signal. The company shows improving quarterly earnings performance, beating expectations in recent quarters, though remains unprofitable with negative margins. Revenue has declined from $676M in 2023 to $548M in 2025, but net losses are narrowing. Analyst sentiment is positive with 60% buy ratings, while technical indicators show bullish moving averages and neutral oscillators.
The outlook suggests potential recovery as earnings improve and losses narrow, supported by analyst optimism. Key risks include persistent negative cash flow, competitive pressures in auto parts e-commerce, and execution challenges in returning to profitability. The stock offers speculative upside if the company can sustain its earnings beat trend and stabilize revenue.
Viatris (VTRS) trades at $17.49, down 0.29% with a bullish technical signal and strong recent earnings beats. The company shows improving operational cash flow of $2.32B in 2025 and positive revenue growth trends, though profitability remains challenged with negative net margins. Recent developments include FDA approval for WAKIX in Japan and consistent dividend payments, supporting the bullish analyst consensus with a $22.17 price target representing 27% upside potential.
The outlook remains cautiously optimistic with strong cash generation supporting shareholder returns, but investors face risks from persistent negative profitability and high debt levels. The stock offers value appeal with reasonable P/S and P/B ratios, though the elevated P/E ratio reflects current earnings challenges that need resolution for sustained re-rating.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →